PAR FY 1990 SALES DOWN 52% TO $49 MIL. WITH LOSS OF $14.8 MIL.; QUAD REGULATORY AUDIT IS IN "EARLY STAGE" BUT ORAL SOLID LINE IS 95% BACK ON LINE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".